Stock Chart

LAB

$0.74 +2.25%
Score: 49.9 HOLD
LEAPs: SELL $2
i
LEAPs Option Signal

Type: SELL wallstreet
Strike: $2
Premium: $0.30
Expiry: May 15, 2026
Target: $2
Score: -83

LEAPs are long-term options (1+ year) with less time decay.
Pro
Screener
Vol: 0.63x (vs SPY: 0.6x | vs QQQ: 0.6x)
Volume Ratio Explained

Vol: Current volume vs 20-day average
vs SPY: Relative activity vs market
vs QQQ: Relative activity vs tech

Color Guide:
● Red (≥1.5x): High activity
● Yellow (≥1.2x): Above average
● Blue (≤0.7x): Low activity

Interpretation:
• vs SPY > 1: Stock-specific interest
• vs SPY < 1: Stock quiet vs market
Chart Pattern · as of Oct 02, 2026
Bull Pennant weak / forming — below our quality gate quality 53/100
A Bull Pennant is taking shape but hasn't passed our quality gate (60/100), so no projected path or levels are shown — only the forming rails on the chart below.
Historically breaks up 70% of the time (n=1,684). Measured-move targets failed our backtest — none shown.
Technical Chart
CHART OVERLAYS
Active: 2
INDICATORS
TRENDLINES
OPTIONS FLOW
VOLUME & PRICE
OTHER

About LAB - Standard BioTools Inc. Common Stock

Standard BioTools Inc develops, manufactures, and sells technologies that help biomedical researchers in their search for developing medicines faster. Its tools provide insights into health and disease using proprietary mass cytometry and microfluidics technologies, which serve applications in proteomics and genomics, respectively. Its segments include Proteomics and Genomics. It generates maximum revenue from the Proteomics segment. Geographically, it derives a majority of its revenue from the Americas.

Key Statistics

Market Cap $286M

This LAB stock chart provides comprehensive technical analysis including candlestick patterns, volume profile analysis, and options open interest data. Track LAB's price movements with trendlines, gamma walls, and key support/resistance levels.